Case Reports and Clinical Evidence While clinical trials of semaglutide have generally shown it to be safe and effective for managing blood sugar levels, there have been isolated case reports of thyroid issues in some patients
2 p=0.08), and no significant publication bias as confirmed by the funnel plot (Fig
Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted from enteroendocrine L-cells, which in turn stimulates insulin secretion, suppresses glucagon secretion, and slows gastric emptying
Understanding these changes is important for informed decision-making about treatment continuation
Rybelsus is not licensed for use as a weight loss medicine, but its active ingredient semaglutide, has been shown to help control appetite by reducing cravings and keeping people feeling fuller for longer
J Am Soc Nephrol 2018;29:118137